Reinach- Evolva (SIX:EVE), a pioneer in the field of natural molecules and industrial biotech, today announced the signing of a distribution agreement with Tovani Benzaquen Ingredients ('Tovani'; tovani.com.br) to jointly develop the Brazilian business for Veri-teTM Resveratrol.

The agreement provides Evolva with access to an attractive segment of the Brazilian market for dietary supplements. Revenues are expected to exceed a minimum of CHF 1.5 million over the next 2.5 years from this partnership. Evolva's Veri-teTM Resveratrol is approved for sale in dietary supplements in Brazil by the Brazilian regulator ANVISA (Agencia Nacional de Vigilncia Sanitaria) and the signing of this distribution agreement with Tovani now allows Evolva to capitalize on the market potential.

Elzo Benzaquen, CEO of Tovani, comments: 'As a leading player in this relevant market segment for Veri-teTM Resveratrol in Brazil, Tovani is keen to develop this business together with our partner Evolva. The trend towards healthier and more conscious lifestyles strongly supports functional ingredients based on nature such as Evolva's Resveratrol. We are excited to offer the differentiating benefits of Veri-teTM Resveratrol, which have been demonstrated in clinical trials such as the reputed RESHAW Study, to our customers.'

Christian Wichert, CEO of Evolva, adds: 'The distribution agreement with Tovani marks an important milestone for our company. It opens-up the Brazilian market for our Veri-teTM Resveratrol offering. Veri-teTM Resveratrol is today the main pillar of our Health Ingredients business and a key contributor to our initiatives to significantly boost future growth. Today's agreement further underlines the positive market momentum for Evolva.'

About Veri-teTM Resveratrol

Resveratrol is a polyphenolic compound that occurs naturally in plant sources such as grapes, peanuts, cranberries and other berries, albeit at low concentrations. Evolva's Veri-teTM Resveratrol is a nature-based high-purity ingredient, made via fermentation, which ensures a stable, traceable and reliable supply. The ingredient is offered in different formats such as a cold-water dispersible or an oil and water soluble resveratrol and is sold to dietary supplements', functional beverages, cosmetics', pharma applications and animal health markets.

About Evolva

Evolva is a Swiss biotech company focused on the research, development and commercialization of ingredients based on nature. The company has leading businesses in Flavors and Fragrances, Health Ingredients and Health Protection. Evolva's employees, half of which are women, are dedicated to make the best products that can contribute to health, wellness and sustainability. Find out more at evolva.com and connect with us on LinkedIn.

For Evolva multimedia content, please visit: evolva.com/multimedia-library.

Important date(s)

August 25, 2022 Half-year 2022 Report

Contact

Thomas Schneckenburger, PhD, CFA

Head of Investor and Corporate Relations

+41 61 485 2003

+41 79 407 9952

thomass@evolva.com

(C) 2022 Electronic News Publishing, source ENP Newswire